Gismo Therapeutics (United States)
- Research works
- 1 ▼ 100% vs 2013–17
- Citations
- 3 4.5 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 50% world 28%
Not ranked overall: Gismo Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Gismo Therapeutics (United States) publish most on?
By volume in 2022–2025: Antiplatelet Therapy and Cardiovascular Diseases, Synthesis of β-Lactam Compounds and Venous Thromboembolism Diagnosis and Management.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Antiplatelet Therapy and Cardiovascular Diseases Cardiology and Cardiovascular Medicine 0 works
- 2 Synthesis of β-Lactam Compounds Organic Chemistry 0 works
- 3 Venous Thromboembolism Diagnosis and Management Internal Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Lexington
- University of Kentucky
- Albert B. Chandler Hospital
- Lexington VA Health Care System
- University of Kentucky HealthCare
- Transylvania University
- Lexington Clinic
- MEP Equine Solutions (United States)
- Lexmark (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.